Nov 30, 2022
Healthcare Inequities Post-Roe: Clinician Perspectives
Many states with abortion bans are also states with higher proportions of people of color, increasing the uneven impacts of the Dobbs decision, which overturned Roe v. Wade.
Search
Shoulder Dystocia Documentation: Implementing a Protocol
Shoulder dystocia claims have traditionally been among the most problematic to defend.
Sep 05, 2025
Record Tribute Plan Milestone: Over $200 Million Distributed to Members
The Doctors Company has now distributed more than $200 million in Tribute® Plan awards to over 15,000 members, and other industry and company news.
From
The Doctor’s Advocate
Nov 27, 2023
Industry and Company News Fourth Quarter 2023
Announcements in the fourth quarter of 2023: ratings affirmations by AM Best and Fitch, two exclusive new endorsements, and Great Place to Work certification.
From
The Doctor’s Advocate
Close the Loop on Test Results
Confirming a colleague’s receipt and understanding of serious findings is part of patient safety. Further, closed-loop communication expresses mutual respect, which contributes to professional satisfaction.
Trends in Medical Malpractice Claims: Social Perception of Healthcare Affects Outcomes in the Courtroom
During the past several years, social perception of healthcare has shifted, and the impact of these negative sentiments is now being felt in the courtroom.
Member Benefits for the American College of Surgeons
The American College of Surgeons (ACS) has offered The Doctors Company’s medical malpractice insurance as a member benefit since 2002.
Exclusively Endorsed by the American College of Cardiology
The American College of Cardiology (ACC) exclusively endorses The Doctors Company’s medical malpractice insurance program.
Medical Advantage Sale
The Doctors Company, part of TDC Group, today announced that it has sold its Medical Advantage subsidiary to Aledade, the nation’s largest network of physician-led value-based care.
AM Best Upgrades Financial Strength Ratings for The Doctors Company
AM Best has upgraded The Doctors Company’s financial strength rating (FSR) to A+ (Superior) from A (Excellent) and the long-term issuer credit rating (ICR) to “aa-” (Superior) from “a+” (Excellent). The outlook of these ratings is stable.